期刊文献+

襻利尿剂在心力衰竭治疗中的应用进展 被引量:2

暂未订购
导出
摘要 随着生活方式的改变及人均寿命的延长,我国心血管疾病的发病率进入快速增长期,2006年我国心血管疾病患者约为2200万,其中心力衰竭患者约为420万。心血管疾病不仅文寸社会及家庭造成了严重影响,还是现阶段人类死亡的首要原因。心力衰竭是多种心血管疾病终末期的一种综合征,同时也是心血管疾病死亡的主要原因。随着循证医学的发展,近年多个国家相继修改或出台心力衰竭诊治指南(以下简称指南),
出处 《河北医药》 CAS 2011年第22期3466-3467,共2页 Hebei Medical Journal
  • 相关文献

参考文献10

  • 1胡盛寿,孔灵芝主编.中国心血管病报告2006.第1版.北京:中国大百科全书出版社,2008.7-10.
  • 2急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:851
  • 3Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the di- agnosis and treatment of acute and chronic heart failure 2008:the task Force for the diagnosis and treatment of Acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine(ESICM). Eur J Heart Fail, 2008,10 : 933 -989.
  • 4Jessup M, Abraham WT, Casey DE, et al. 2009 focused update : ACCF/ AHA Guidelines for the Diagnosis and Management of Heart Failure in A- dults:a report of the American College of Cardiology Foundation/Ameri- can Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplan- tation. Circulation .2009.119: 1977-2016.
  • 5Hunt SA,Abrabam WT,Chin MH,et al. ACC/AHA 2005 Guideline Up- date for the Diagnosis and Management of Chronic Heart Failure in the Adult:a report of the American College, of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) :developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplanta- tion : endorsed by the Heart Rhythm Society. Circulation, 2005,112 : 154- 235.
  • 6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure : executive summary ( update 2005 ) : The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J ,2005,26 : 1115-1140.
  • 7李小鹰主编.心血管药理学.第3版.北京:人民卫生出版社,2008.388-425.
  • 8Kaojarern S, Day B, Brater DC. The time course of delivery of furosemide into urine:an independent determinant of overall response. Kidney Int, 1982,22:69-74.
  • 9Hammarlund MM, Odlind B, Paalzow LK. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. J Phar- macol Exp Ther, 1985,233:447-453.
  • 10陈灏珠.心脏病学.第7版.北京:人民卫生出版社,2007:402.

二级参考文献39

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2中华医学会心血管病学分会 中华心血管病杂志编辑委员会.β肾上腺素能受体阻滞剂在心血管疾病应用的专家共识[J].中华心血管病杂志,2009,37:195-209.
  • 3中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 4Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26: 384-416.
  • 5Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29 : 2388-2442.
  • 6Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fa/lure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005, 46: e1-e82.
  • 7Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Aduks: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines : developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation, 2009, 119: 1977-2016.
  • 8Liang KV, Williams AW, Greene EL, et al. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med, 2008, 36(1 Suppl) : S75-S88.
  • 9Chen D, Assad-Kottner C, Orrego C, et al. Cytokines and acute heart failure. Crit Care Med, 2008, 36(1 Suppl) : S9-S16.
  • 10Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 2006, 27 : 839-845.

共引文献851

同被引文献19

  • 1赵民生,曹秀虹.利尿剂在治疗心血管疾病时的不良反应及处理[J].药学实践杂志,2006,24(6):353-354. 被引量:6
  • 2Grimn RH Jr,Grandits GA,Prinease RJ,et al.Long term effects on sexual funcation of five antihyper-tensive drugs and nutrition hygienic treat- ment of hypertension study[J].Hypertension,1997,29(1):8.
  • 3Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update:a report from the American Heart Association I J 1. Circulation, 2010,123 : el 8 -e209.
  • 4Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive sum- mary:heart disease and stroke statistics-2010 update: a report from the American Heart Association [ J]. Circulation, 2010, 121:948-954.
  • 5Fads R, Flather M, Purcell H, et al. Current evidence sup- porting the role of diuretics in heart failure: a meta analysis of randomised controlled trials [ J ]. Int J Cardiol, 2002,82 ( 2 ) : 149-158.
  • 6Fads R,Purcell H,Poole-Wilson PA,et al. Diuretics for heart fail- ure [ J ]. Cochrane Database Syst Rev ,2006, ( 1 ) :3838-3841.
  • 7Eshagllian S, Horwich TB, Fonamw GC. Relation of loop diu- retics dose to mortality in advanced heart failure E J ]. Am J Cardio1,2006,97 ( 12 ) : 1759-1764.
  • 8Sata Y, Krum H. The future of pharmacological therapy for heart failure [ J ]. Circ J,2010,74 (5) : 809-817.
  • 9Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis [ J ]. J Cell Physiol, 2010, 225(3) :631-637.
  • 10Dobaczewski M, Bujak M, Li N, et al. Smad3 signaling criti- cally regulates fibroblast phenotype and function in healing myocardial infarction I J ]. Circ Res,2010,107:418-428.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部